Literature DB >> 27797257

Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients.

Lukasz Pietrzyk1, Zbigniew Plewa, Marta Denisow-Pietrzyk, Remigiusz Zebrowski, Kamil Torres.   

Abstract

BACKGROUND: Gastric cancer (GC) is the fifth most common cancer worldwide. Since development is usually asymptomatic, it is generally diagnosed at an advanced stage. The value of screening in patients with nonspecific symptoms for GC is controversial. AIM: The study aimed to evaluate whether hematological parameters (platelet count (PC), mean platelet volume (MPV), MPV/PC ratio, red blood cell distribution width (RDW), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR)) are useful markers to differentiate between gastric cancer patients and healthy individuals.
MATERIALS AND METHODS: Sixty-one patients with gastric cancer and sixty-one healthy individuals were enrolled to the survey and a retrospective analysis of selected blood parameters was performed.
RESULTS: The mean values of PC, MPV, RDW, NLR, and PLR were significantly higher in GC patients compared to the control group. No statistical differences were observed in MPV/PC ratios. Likewise, no significant statistical differences were revealed in values of blood parameters among TNM stage groups. The RDW showed the highest diagnostic specificity and sensitivity.
CONCLUSIONS: Hematological parameters: PC, MPV, RDW, NLR, PLR have diagnostic power and can discriminate patients with gastric cancer from patients without cancer. Blood parameters compared with clinical symptoms might alert physicians and patients and lead to performancce of upper gastrointestinal endoscopy, the gold standard in gastric cancer screening and thereby increase the early detection of cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797257

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  30 in total

1.  The postoperative platelet distribution width is useful for predicting the prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Tomoyuki Matsunaga; Hiroaki Saito; Yoji Fukumoto; Shota Shimizu; Yusuke Kono; Yuki Murakami; Yuji Shishido; Kozo Miyatani; Manabu Yamamoto; Naruo Tokuyasu; Shuichi Takano; Teruhisa Sakamoto; Soichiro Honjo; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2019-08-06       Impact factor: 2.549

2.  Prognostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Head and Neck Malignancies.

Authors:  Yanish Bhashkar Seetohul; Vishwambhar Singh; Rajiv Kumar Jain; Ashvanee Kumar Chaudhary
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-11-25

3.  Clinical Significance of Routine Blood Test-Associated Inflammatory Index in Breast Cancer Patients.

Authors:  Hong Sun; Chang-Qing Yin; Qing Liu; Fubing Wang; Chun-Hui Yuan
Journal:  Med Sci Monit       Date:  2017-10-25

Review 4.  Prognostic significance of red blood cell distribution width in gastrointestinal disorders.

Authors:  Hemant Goyal; Giuseppe Lippi; Altin Gjymishka; Bijo John; Rajiv Chhabra; Elizabeth May
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

5.  Higher platelet distribution width predicts poor prognosis in laryngeal cancer.

Authors:  Huan Zhang; Li Liu; Shuang Fu; Yan-Song Liu; Changsong Wang; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Oncotarget       Date:  2017-07-18

6.  Lower mean platelet volume predicts poor prognosis in renal cell carcinoma.

Authors:  Zhi-Yuan Yun; Xin Zhang; Yan-Song Liu; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

7.  Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer.

Authors:  Shubin Song; Chunfeng Li; Sen Li; Hongyu Gao; Xiuwen Lan; Yingwei Xue
Journal:  Onco Targets Ther       Date:  2017-06-26       Impact factor: 4.147

8.  Increased platelet distribution width predicts poor prognosis in melanoma patients.

Authors:  Na Li; Zhiyong Diao; Xiaoyi Huang; Ye Niu; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

9.  Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.

Authors:  Xin Wang; Ming-Ming Cui; Yangyang Xu; Li Liu; Ye Niu; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Oncotarget       Date:  2017-07-12

10.  Elevated mean platelet volume predicts poor prognosis in colorectal cancer.

Authors:  Na Li; Zhiwei Yu; Xin Zhang; Tiemin Liu; Yu-Xiang Sun; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.